Nature Communications (Mar 2021)

Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling

  • Ismael A. Vergara,
  • Christopher P. Mintoff,
  • Shahneen Sandhu,
  • Lachlan McIntosh,
  • Richard J. Young,
  • Stephen Q. Wong,
  • Andrew Colebatch,
  • Daniel L. Cameron,
  • Julia Lai Kwon,
  • Rory Wolfe,
  • Angela Peng,
  • Jason Ellul,
  • Xuelin Dou,
  • Clare Fedele,
  • Samantha Boyle,
  • Gisela Mir Arnau,
  • Jeanette Raleigh,
  • Athena Hatzimihalis,
  • Pacman Szeto,
  • Jennifer Mooi,
  • Daniel S. Widmer,
  • Phil F. Cheng,
  • Valerie Amann,
  • Reinhard Dummer,
  • Nicholas Hayward,
  • James Wilmott,
  • Richard A. Scolyer,
  • Raymond J. Cho,
  • David Bowtell,
  • Heather Thorne,
  • Kathryn Alsop,
  • Stephen Cordner,
  • Noel Woodford,
  • Jodie Leditschke,
  • Patricia O’Brien,
  • Sarah-Jane Dawson,
  • Grant A. McArthur,
  • Graham J. Mann,
  • Mitchell P. Levesque,
  • Anthony T. Papenfuss,
  • Mark Shackleton

DOI
https://doi.org/10.1038/s41467-021-21576-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

The genetic changes that occur in late stage metastatic melanoma are not well delineated. Here, the authors use rapid autopsy samples from metastatic melanoma patients and show that the late stage in the disease is characterised by whole genome doubling and aneuploidy.